advertisement
Journal of Ocular Pharmacology and Therapeutics 32
Showing records 1 to 25 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics59909 The circadian changes of intraocular pressure and ocular perfusion pressure after tafluprost compared with travoprost in normal tension glaucoma
Shin J
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 803-809
60537 Beneficial Effects of Adjuvant Intravitreal Bevacizumab Injection on Outcomes of Ahmed Glaucoma Valve Implantation in Patients with Neovascular Glaucoma: Systematic Literature Review
Hwang HB
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 198-203
60335 Long-term effect of latanoprost on central corneal thickness in normal-tension glaucoma: five-year follow-up results
Lee H
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 152-155
60524 Comparison of the Toxicity Profile of Benzalkonium Chloride-Preserved Tafluprost and SofZia-Preserved Travoprost Applied to the Ocular Surface
Kanamoto T
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 156-164
60271 Pharmacotherapy of glaucoma
Schmidl D
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 63-77
60295 Novel potential treatment modalities for ocular hypertension: focus on Angiotensin and bradykinin system axes
Sharif NA
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 131-145
60538 A Model-Based Dose-Response Meta-Analysis of Ocular Hypotensive Agents as a Drug Development Tool to Evaluate New Therapies in Glaucoma
Raber S
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 189-197
60621 Effect of AR-13324 on Episcleral Venous Pressure in Dutch Belted Rabbits
Kiel JW
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 146-151
60335 Long-term effect of latanoprost on central corneal thickness in normal-tension glaucoma: five-year follow-up results
Cho BJ
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 152-155
60538 A Model-Based Dose-Response Meta-Analysis of Ocular Hypotensive Agents as a Drug Development Tool to Evaluate New Therapies in Glaucoma
Mandema JW
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 189-197
60621 Effect of AR-13324 on Episcleral Venous Pressure in Dutch Belted Rabbits
Kopczynski CC
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 146-151
59909 The circadian changes of intraocular pressure and ocular perfusion pressure after tafluprost compared with travoprost in normal tension glaucoma
Lee JW
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 803-809
60537 Beneficial Effects of Adjuvant Intravitreal Bevacizumab Injection on Outcomes of Ahmed Glaucoma Valve Implantation in Patients with Neovascular Glaucoma: Systematic Literature Review
Han JW
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 198-203
60524 Comparison of the Toxicity Profile of Benzalkonium Chloride-Preserved Tafluprost and SofZia-Preserved Travoprost Applied to the Ocular Surface
Kiuchi Y
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 156-164
60271 Pharmacotherapy of glaucoma
Schmetterer L
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 63-77
60538 A Model-Based Dose-Response Meta-Analysis of Ocular Hypotensive Agents as a Drug Development Tool to Evaluate New Therapies in Glaucoma
Li H
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 189-197
60537 Beneficial Effects of Adjuvant Intravitreal Bevacizumab Injection on Outcomes of Ahmed Glaucoma Valve Implantation in Patients with Neovascular Glaucoma: Systematic Literature Review
Yim HB
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 198-203
60271 Pharmacotherapy of glaucoma
Garhöfer G
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 63-77
59909 The circadian changes of intraocular pressure and ocular perfusion pressure after tafluprost compared with travoprost in normal tension glaucoma
Choi BS
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 803-809
60524 Comparison of the Toxicity Profile of Benzalkonium Chloride-Preserved Tafluprost and SofZia-Preserved Travoprost Applied to the Ocular Surface
Tanito M
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 156-164
60271 Pharmacotherapy of glaucoma
Popa-Cherecheanu A
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 63-77
60538 A Model-Based Dose-Response Meta-Analysis of Ocular Hypotensive Agents as a Drug Development Tool to Evaluate New Therapies in Glaucoma
Nickens DJ
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 189-197
59909 The circadian changes of intraocular pressure and ocular perfusion pressure after tafluprost compared with travoprost in normal tension glaucoma
Yun EY
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 803-809
60524 Comparison of the Toxicity Profile of Benzalkonium Chloride-Preserved Tafluprost and SofZia-Preserved Travoprost Applied to the Ocular Surface
Mizoue S
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 156-164
60537 Beneficial Effects of Adjuvant Intravitreal Bevacizumab Injection on Outcomes of Ahmed Glaucoma Valve Implantation in Patients with Neovascular Glaucoma: Systematic Literature Review
Lee NY
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 198-203